[Ningbo Zhenyu Technology 2025 Semi-Annual Performance Forecast](index=1&type=section&id=Ningbo%20Zhenyu%20Technology%20Co.%2C%20Ltd.%202025%20Semi-Annual%20Performance%20Forecast) [Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Projection) The company forecasts a significant increase in H1 2025 net profit attributable to shareholders and non-recurring adjusted net profit, ranging from 40.45% to 66.85% Performance Projection | Item | Current Reporting Period (Jan 1 - Jun 30, 2025) | Prior Period | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders of Listed Company** | **Profit: RMB 185.00 million – RMB 212.00 million**<br>Year-on-year Growth: 40.45% – 60.95% | Profit: RMB 131.72 million | | **Net Profit After Deducting Non-Recurring Gains and Losses** | **Profit: RMB 175.00 million – RMB 200.00 million**<br>Year-on-year Growth: 45.99% – 66.85% | Profit: RMB 119.868 million | [Audit and Communication Status](index=1&type=section&id=II.%20Communication%20with%20Accounting%20Firm) The financial data in this performance forecast represents preliminary estimates by the company's finance department and has not yet been audited by a certified public accountant - Performance forecast data is a preliminary estimate by the company's finance department and is unaudited[4](index=4&type=chunk) [Analysis of Performance Changes](index=1&type=section&id=III.%20Explanation%20of%20Performance%20Changes) The primary drivers for year-on-year performance growth include sustained sales order increases and enhanced overall economic efficiency from technological R&D, production automation, and cost reduction initiatives - Performance growth is primarily attributed to[5](index=5&type=chunk) - Sustained growth in sales orders - Increased investment in technology research and development - Enhanced production automation levels - Effective cost reduction and efficiency improvement measures [Risk Warning and Other Disclosures](index=2&type=section&id=IV.%20Other%20Relevant%20Disclosures) The company advises investors that this performance forecast is preliminary and unaudited, with final accurate financial data to be disclosed in the 2025 semi-annual report, urging cautious investment decisions and awareness of risks - The company advises that this performance forecast is a preliminary estimate, with final data subject to the 2025 semi-annual report, cautioning investors about investment risks[6](index=6&type=chunk) [Reference Documents](index=2&type=section&id=V.%20Reference%20Documents) The board of directors' explanatory statement regarding this semi-annual performance forecast is available as a reference document - The board of directors' explanatory statement on the 2025 semi-annual performance forecast is available for reference[7](index=7&type=chunk)

Group 1 - The humanoid robot sector is experiencing significant activity, with the Yush Robot Index rising by 3.14% and several companies, including Yush Technology and Longsheng Bearing, achieving maximum daily gains [1] - A major procurement announcement from China Mobile revealed that Zhiyuan Robotics and Yush Technology won a contract for humanoid biped robot manufacturing services, totaling 124 million yuan, marking the highest single procurement in China's humanoid robot sector [1] - Investment in the humanoid robot field is accelerating, with companies like Xinghai Tu and Beijing Xingdong Jiyuan completing significant funding rounds, contributing to a total financing amount exceeding 23 billion yuan in the first five months of the year [1] Group 2 - Fund products from Fangzheng Fubon, such as Fangzheng Fubon Xinhong Flexible Allocation Mixed Fund and Fangzheng Fubon Technology Innovation Mixed Fund, are heavily invested in the humanoid robot sector, showing strong performance in their top holdings [2] - For instance, Fangzheng Fubon Xinhong's top holdings, including Shuanglin Co. and Zhenyu Technology, saw gains exceeding 5%, while the fund itself achieved a net value increase of 18.68% over the past six months [2] Group 3 - In the automotive sector, UBTECH's WalkerS series humanoid robots are being utilized by major manufacturers like NIO and BYD for quality inspection and labeling tasks, contributing to automation in parts warehousing [3] - In the pharmaceutical industry, Yuejiang has partnered with Yaoshibang to explore smart solutions across various applications, including drug research and delivery [3] - The infrastructure inspection sector is benefiting from the deployment of Yunshen's "Jueying" quadruped robots in Singapore's national grid, enhancing inspection efficiency and safety [3]

Investment Rating - The report maintains a "Positive" outlook for the machinery equipment industry [6]. Core Insights - The humanoid robot industry is on the verge of mass production, driven by hardware optimization and breakthroughs in intelligent technology. Domestic leading robot companies are expected to accelerate their listing processes, creating investment opportunities [3][9]. - Key developments include the release of advanced AI models like Grok4, which enhance the capabilities of humanoid robots, improving task understanding and execution efficiency [9]. - The report highlights the positive signals from both domestic and international markets, with significant capital inflow expected to support technological innovation and market expansion [9]. Summary by Sections Investment Recommendations and Targets - The report suggests focusing on three categories of quality targets within the industry: 1. Companies with strong ties to leading domestic and international clients and strategic positioning 2. Companies with forward-looking layouts and guaranteed mass production capabilities 3. Companies with strong cost-reduction capabilities, which are likely to benefit first during the industry's growth phase - Recommended stocks include: Wuzhou New Spring (603667, Buy), Zhenyu Technology (300953, Buy), Saimo Intelligent (300466, Not Rated), Bozhong Precision (688097, Not Rated), and Lingyi Manufacturing (002600, Buy) [3]. Industry Dynamics - The humanoid robot industry is experiencing a significant shift towards mass production, with international leaders like Figure ramping up production capabilities and reducing costs by 90% for their latest models [9][11]. - The report notes that the domestic capital market is showing positive trends, with several leading robot companies planning to go public, which will inject strong growth momentum into the industry [9][11]. Recent Developments - Key events in the humanoid robot industry include significant financing rounds and product launches, such as the completion of a 500 million yuan A-round financing by Xingdong Jiyuan and the introduction of the MagicBot Z1 by Magic Atom [11][12]. - The report also highlights the upcoming Asia-Pacific International Smart Equipment Expo and other industry conferences, indicating a growing interest and investment in the humanoid robotics sector [12].

证券代码：300953 证券简称：震裕科技 公告编号：2025-079 宁波震裕科技股份有限公司 | 委托方 | 受托方 | 产品名称 | 产品类 型 | 金额 | 起息日 | 到期日 | 预计年化 收益率 | | --- | --- | --- | --- | --- | --- | --- | --- | | 苏州范 | 浙商银 | 单位一个 | | | | | | | 斯特机 | | | | | | | | | 械科技 | 行股份 | 月期挂钩 | 保本浮 | | | | 1.00%或 | | | 有限公 | 汇率（欧 | | | 2025-07- | 2025-08- | | | 有限公 | | | 动收益 | 2,000 | | | 1.80%或 | | | 司宁波 | 元兑美 | | | 11 | 11 | | | 司募集 | | | 型 | | | | 2.45% | | | 宁海支 | 元）看跌 | | | | | | | 资金专 | | | | | | | | | 户 | 行 | 25027 期 | | | | | | | 委托方 | 受托方 | 产品名称 | 产品类 | 金额 | 起息日 ...

Core Viewpoint - Ningbo Zhenyu Technology Co., Ltd. has announced the grant of reserved restricted stocks under the 2024 Restricted Stock Incentive Plan, with a total of 700,000 shares to be granted at a price of 19.50 yuan per share, effective from July 2, 2025 [1][10][11]. Summary by Sections 1. Overview of the 2024 Restricted Stock Incentive Plan - The plan involves granting restricted stocks sourced from repurchased shares or newly issued A-shares [1]. - The total number of reserved restricted stocks is 700,000, accounting for 1% of the company's total share capital [3][13]. 2. Granting Objects and Quantities - The granting objects include core management and technical personnel, with a total of 220 individuals receiving 403,850 shares, of which 353,850 are for initial grants and 50,000 are reserved [2][11]. - The reserved portion will be granted to 11 individuals, totaling 700,000 shares [11][18]. 3. Granting Price and Conditions - The initial granting price for the restricted stocks is set at 27.51 yuan per share, which has been adjusted to 19.50 yuan for the reserved stocks [10][12]. - The granting conditions have been met as per the company's internal regulations and relevant laws [12][19]. 4. Vesting Arrangements - The vesting schedule for the restricted stocks includes three phases, with the first vesting occurring 12 months after the grant date [4][14]. - The reserved stocks will follow a similar vesting schedule based on the timing of their grant [14]. 5. Performance Assessment Requirements - The performance assessment for the initial grant will be based on net profit and operating income targets for the fiscal years 2024 to 2026 [5][6]. - The performance targets will determine the vesting ratio, with specific thresholds set for each year [6][7]. 6. Approval Process and Disclosure - The incentive plan has undergone necessary approvals from the board and supervisory committee, with public disclosure of the granting objects and conditions [8][9]. - The plan has been publicly announced and is compliant with relevant regulations [19][21]. 7. Financial Impact and Accounting Treatment - The fair value of the restricted stocks will be calculated using the Black-Scholes model, impacting the company's financial statements over the vesting period [15][16]. - The estimated costs associated with the stock grants will be amortized and reflected in the company's financial results [15][16]. 8. Legal and Independent Financial Advisor Opinions - Legal and financial advisors have confirmed that the adjustments to the granting price and quantity comply with applicable laws and regulations, ensuring no harm to the interests of shareholders [19][21].

Core Viewpoint - The company has reviewed and approved the list of reserved grant recipients for the 2024 restricted stock incentive plan, ensuring compliance with relevant laws and regulations [1][2]. Group 1: Compliance and Eligibility - The reserved grant recipients do not fall under any disqualifying conditions as per the Management Measures and Listing Rules [1]. - The recipients include company directors, senior management, core technical personnel, and other key management staff, all of whom are employed by the company and have signed relevant contracts [1][2]. - Independent directors, supervisors, foreign employees, and shareholders or actual controllers holding more than 5% of the company's shares are excluded from the incentive plan [1]. Group 2: Plan Details - The reserved grant recipients meet the qualifications stipulated in the Company Law, Securities Law, and other relevant regulations, confirming their eligibility for the incentive plan [2]. - The list of reserved grant recipients aligns with the recipients approved at the company's third extraordinary general meeting for the 2024 restricted stock incentive plan [2]. - The company plans to reserve 700,000 shares of the second category of restricted stock for 11 eligible recipients, with the reserved grant date set for July 2, 2025 [2].

证券代码：300953 证券简称：震裕科技 公告编号：2025-075 宁波震裕科技股份有限公司 关于调整 2022 年限制性股票激励计划授予价格及授予数量 的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 根据宁波震裕科技股份有限公司（以下简称"公司"）2022 年第三次临时股 东大会授权，公司于 2025 年 7 月 2 日召开第五届董事会第七次会议、第五届监 事会第五次会议，审议通过了《关于调整 2022 年限制性股票激励计划授予价格 及授予数量的议案》。现将有关事项说明如下： 一、本次激励计划已履行的审批程序和信息披露情况 （一）2022 年 3 月 22 日，公司召开第四届董事会第四次会议，会议审议通 过了《关于〈宁波震裕科技股份有限公司 2022 年限制性股票激励计划（草案）〉 及其摘要的议案》《关于〈宁波震裕科技股份有限公司 2022 年限制性股票激励 计划实施考核管理办法〉的议案》以及《关于提请股东大会授权董事会办理 2022 年限制性股票激励计划相关事宜的议案》等议案。公司独立董事就本激励计划相 关议案发表了独立意见。 同日，公司召开第 ...

宁波震裕科技股份有限公司 调整授予价格及授予数量及 2024 年限制性股票 激励计划预留授予相关事项 之 独立财务顾问报告 证券简称：震裕科技 证券代码：300953 上海荣正企业咨询服务（集团）股份有限公司 关于 2025 年 7 月 | 一、释义 | 3 | | --- | --- | | 二、声明 | 4 | | 三、基本假设 | 5 | | 四、股权激励计划的批准与授权 | 6 | | （一） 2022 年激励计划已履行的审批程序 | 6 | | （二） 2024 年激励计划已履行的审批程序 | 8 | | 五、独立财务顾问意见 | 10 | | （一） | 本次限制性股票授予数量及授予价格的调整情况 10 | | （二） 2024 | 年限制性股票预留授予条件成就的情况说明 10 | | （三） 2024 | 年激励计划限制性股票的预留授予情况 11 | | （四） | 实施本次激励计划对相关年度财务状况和经营成果影响的说明 12 | | （五） 结论性意见 | 12 | | 五、备查文件及咨询方式 | 13 | | （一）备查文件 13 | | | （二）咨询方式 13 | | 一、释义 | 震裕 ...

法律意见书 浙江天册律师事务所 关于 宁波震裕科技股份有限公司 调整 2024 年限制性股票激励计划授予价格、授予数量 及向激励对象授予预留限制性股票事项的 法律意见书 浙江省杭州市杭大路 1 号黄龙世纪广场 A 座 11 楼 310007 电话：0571-87901111 传真：0571-87901500 法律意见书 释 义 在本法律意见书中，除非文意另有所指，下列词语具有下述涵义： | 本所 | 浙江天册律师事务所 | | | --- | --- | --- | | 公司/震裕科技 | 宁波震裕科技股份有限公司 | | | 本次股权激励计划/本激励计划/ | 宁波震裕科技股份有限公司 2024 | 年限制性股票 | | 激励计划 | 激励计划 | | | 《激励计划（草案）》 | 《宁波震裕科技股份有限公司 2024 | 年限制性股票 | | | 激励计划（草案）》 | | | 《考核管理办法》 | 《宁波震裕科技股份有限公司 2024 | 年限制性股票 | | | 激励计划实施考核管理办法》 | | | 《证券法》 | 《中华人民共和国证券法》 | | | 《公司法》 | 《中华人民共和国公司法》 | ...

宁波震裕科技股份有限公司 2025 年 7 月 2 日 序 号 姓名 类别 序 号 姓名 类别 1 汤*凯 核心管理人员、核心技术 （业务）人员 5 马* 核心管理人员、核心技术 （业务）人员 2 檀*本 核心管理人员、核心技术 （业务）人员 6 邬*宾 核心管理人员、核心技术 （业务）人员 3 许* 核心管理人员、核心技术 （业务）人员 7 王*峰 核心管理人员、核心技术 （业务）人员 4 王* 核心管理人员、核心技术 （业务）人员 8 陈* 核心管理人员、核心技术 （业务）人员 二、核心管理人员、核心技术（业务）人员名单 2、任何一名激励对象通过全部在有效期内的股权激励计划获授的本公司股票数量累计 不超过公司股本总额的 1%。公司全部有效期内的激励计划所涉及的标的股票总数累计不超 过股权激励计划提交股东大会审议时公司股本总额的 20%。 姓名 职务 获授的限制性股 票数量（万股） 占本激励计划 预留授予限制性 股票总数的比例 占公司股本 总额的比例 周茂伟 董事、副总经理 13.00 18.57% 0.07% 彭勇泉 副总经理、董事会 秘书 14.00 20.00% 0.08% 刘赛萍 财务总监 7.00 ...